One of the best things about EasyEquities is our community β hundreds of thousands of passionate, smart and engaged South Africans who continue to positively change the investment landscape. And with the additions to our loyalty programme, Thrive, that progress is set to accelerate.
On 31 October, the EasyEquities community got information on the enhancements to Thrive β which has been part of EasyEquities for many years. Thrive enhancements were announced after months of research, engagement with many users and partners, debates and use of the rich data of the EasyEquities community.
The feedback on the announcement has been appreciated and will continue to inform future developments. Yep, at EasyEquities, we love designing products based on user needs and input. The quickest way to get your views heard is to log a ticket.
Thrive highlights include:
Activities that get users to level 3 include:
Other Thrive activities include:
Carel Nolte, Chief Enablement Officer at EasyEquities, said: βOur hope is that no member of the EasyEquities community ever gets charged a Thrive fee. We want all our users to join the many thousands who already Thrive via great, sustainable financial habits.β
Further adding that: βIt is a proven fact that people who display the behaviours Thrive promotes, are more likely to achieve financial freedom. As a company, investors and society, we canβt simply pay lip service to growing financial literacy and opportunities β it requires a little effort. Users who pitch up and engage will pay no fee, get discounts and other benefits and continue to have safe, free, easy and fun access to a variety of investment options β South African, USA, Australian, European and British equities; unit trusts and EFTs from a variety of product providers like Satrix, Allan Gray, PSG, Sanlam (which owns 30% of EasyEquities) M&G, Coronation and Sygnia to name a few. Not to mention crypto bundles and coins, property and features such as quick and easy FX transfer, EasyCredit, EasyProtect, educational blogs and research.β